The Eggerthellaceae family has garnered significant attention in next-generation probiotic research due to its specialized capability to metabolize dietary ellagitannins and ellagic acid into beneficial compounds such as urolithins, notably isolecithine-A. Recognizing the profound potential of these bacteria, Creative Biolabs offers cutting-edge probiotic development services, supporting researchers globally to leverage Eggerthellaceae probiotics for advanced microbiome modulation.
Eggerthellaceae family members, belonging to the Actinobacteria phylum, include anaerobic bacteria instrumental in the biotransformation of dietary polyphenols. This family uniquely metabolizes ellagic acid—derived from ellagitannins found in pomegranates, berries, and nuts—into bioactive urolithins. Among these metabolites, isolecithine-A stands out due to its robust biological activity, significantly enhancing polyphenol benefits through improved bioavailability.
The transformation from ellagic acid to isolecithine-A involves enzymatic pathways mediated by specific bacterial strains, highlighting the importance of these microbes in gut microbiota research and microbiome modulation strategies.
The shift towards next-generation probiotics emphasizes the development of microbial strains with targeted functionalities beneficial to host health. Eggerthellaceae probiotics exemplify this paradigm through their specialized ability to produce urolithins, significantly influencing gut microbial ecology and metabolic profiles. At Creative Biolabs, we provide integrated probiotic development solutions, leveraging advanced microbiological, biochemical, and genomic technologies to maximize the potential of Eggerthellaceae probiotics:
We utilize state-of-the-art genomic sequencing, bioinformatics tools, and cultivation techniques to discover and isolate robust, urolithin-producing Eggerthellaceae strains. Our meticulous identification processes ensure accurate strain classification and high metabolic potential for consistent probiotic application.
Our high-throughput screening platform quantifies each strain's ability to transform ellagic acid into urolithins, while in-depth enzymatic and pathway mapping reveals the precise mechanisms of action driving polyphenol bioconversion.
Ensuring probiotics retain stability and viability is crucial for research applicability. Creative Biolabs performs rigorous evaluations under simulated gastrointestinal conditions, confirming the robustness and sustained metabolic activity of Eggerthellaceae probiotics throughout experimental use.
Safety is paramount in probiotic research. We conduct meticulous in vitro and preclinical evaluations to confirm the suitability and safety of selected strains for laboratory research environments, adhering to rigorous scientific standards and regulatory guidelines.
Our platform integrates cutting-edge genomic and metabolomic analyses to accurately characterize and optimize the probiotic functionalities of Eggerthellaceae strains. This detailed microbial profiling enables researchers to fully understand and harness the probiotic potential of selected microbes.
Our expertise in developing stable, viable formulations addresses the challenges inherent in handling anaerobic Eggerthellaceae bacteria. We provide customized probiotic formulations suitable for diverse research methodologies, ensuring practical and reliable experimental outcomes.
To support the high-value development of urolithin-producing probiotics, Creative Biolabs integrates a set of critical technologies designed for precise strain validation and functional profiling. Each selected technology is directly relevant to the biological characteristics and research utility of Eggerthellaceae family members.
Eggerthellaceae strains are strictly anaerobic and often sensitive to external conditions, making their ability to adhere to intestinal epithelium a crucial indicator of probiotic potential. Adhesion assays are used to evaluate the interaction between candidate strains and Caco-2 or HT-29 epithelial cells, determining colonization capacity and persistence in the gut—key for metabolic activity such as ellagic acid biotransformation.
Since urolithins, especially isourolithin A, have demonstrated anti-inflammatory effects in various models, it's essential to verify whether the probiotic strain contributes to anti-inflammatory activity. We use TNF-α/LPS-stimulated macrophage models (e.g., RAW264.7) to assess NO, IL-6, and IL-1β secretion. This step links microbial metabolism to host immune modulation, a hallmark of next-generation probiotics.
To validate in vivo colonization and urolithin production, Creative Biolabs integrates fecal microbiota sampling from germ-free or antibiotic-treated mice. These models allow controlled colonization with specific Eggerthellaceae strains. Fecal sampling is followed by metabolite profiling (e.g., LC-MS of urolithin A) and 16S rRNA tracking of colonization efficiency.
Short-chain fatty acids (SCFAs), though not direct products of ellagic acid metabolism, are crucial functional markers of probiotic metabolic activity and microbiome modulation. Eggerthellaceae may indirectly influence SCFA profiles through cross-feeding with other gut microbes. GC and HPLC are used to quantify acetate, propionate, and butyrate in fermentation supernatants.
The acid and bile tolerance of Eggerthellaceae strains is critical for their function as oral probiotics. Survival assays simulate gastric juice (pH ~2.0) and bile salt environments to assess strain viability. This directly informs formulation strategies and delivery route design for research applications.
Complementing our probiotic development solutions, Creative Biolabs also provides an array of specialized Eggerthellaceae-related products:
CAT | Product Name | Target | Product Overview |
---|---|---|---|
LBST-074FG | Eggerthellaceae sp. | Eggerthellaceae | The Eggerthellaceae is a family of Gram-positive, rod- or coccus-shaped Actinobacteria. It is the sole family within the order Eggerthellales. |
LBST-075FG | Adlercreutzia equolifaciens | Eggerthellaceae | Adlercreutzia equolifaciens is an anaerobe, mesophilic, Gram-positive Actinobacterium that was isolated from human faeces. |
LBST-076FG | Adlercreutzia equolifaciens; 54925 | Eggerthellaceae | Adlercreutzia equolifaciens is an anaerobe, mesophilic, Gram-positive Actinobacterium that was isolated from human faeces. |
LBST-077FG | Cryptobacterium curtum; 45151 B | Eggerthellaceae | Cryptobacterium curtum was isolated from human blood. It is a Gram-positive, obligately anaerobic, non-spore-forming, and rod-shaped bacteria. |
LBST-078FG | Cryptobacterium curtum; 55333T | Eggerthellaceae | Cryptobacterium curtum was isolated from human periodontal pocket. It is a Gram-positive, obligately anaerobic, non-spore-forming, and rod-shaped bacteria. |
LBST-079FG | Cryptobacterium curtum; 12-3 | Eggerthellaceae | Cryptobacterium curtum was isolated from peridontal pocket of an adult with peridontal disease. It is a Gram-positive, obligately anaerobic, non-spore-forming, and rod-shaped bacteria. |
LBST-080FG | Denitrobacterium detoxificans; NPOH2 | Eggerthellaceae | Denitrobacterium detoxificans was isolated from bovine rumen contents. It is the only described species in the Denitrobacterium genus. |
LBST-081FG | Gordonibacter pamelaeae; 55131T | Eggerthellaceae | Gordonibacter pamelaeae is an anaerobe, mesophilic, Gram-positive bacterium that was isolated from human intestinal biopsy. |
LBST-082FG | Gordonibacter urolithinfaciens; 64261T | Eggerthellaceae | Gordonibacter urolithinfaciens was isolated from human feces. It is a Gram-positive bacteria belonging to the recent family Eggerthellaceae. |
LBST-083FG | Gordonibacter urolithinfaciens; 27213 | Eggerthellaceae | Gordonibacter urolithinfaciens was isolated from human feces of a healthy volunteer. It is a Gram-positive bacteria belonging to the recent family Eggerthellaceae. |
LBST-084FG | Gordonibacter pamelaeae | Eggerthellaceae | Gordonibacter pamelaeae is an anaerobe, mesophilic, Gram-positive bacterium that was isolated from patient with active Crohn's disease. |
LBST-085FG | Paraeggerthella hongkongensis | Eggerthellaceae | Paraeggerthella hongkongensis is an anaerobe, mesophilic bacterium that was isolated from blood from a patient with perianal abscess. |
LBST-086FG | Slackia equolifaciens | Eggerthellaceae | Slackia equolifaciens was isolated from human feces. It is an equol-producing bacterium. |
LBST-087FG | Slackia exigua; 36663 | Eggerthellaceae | Slackia exigua was isolated from human oral abscess. It is a Gram-positive bacterium. |
LBST-088FG | Slackia exigua; 445bbT | Eggerthellaceae | Slackia exigua was isolated from human necrotic pulp of tooth. It is a Gram-positive bacterium. |
LBST-089FG | Slackia equolifaciens; 58231T | Eggerthellaceae | Slackia equolifaciens was isolated from human feces. It is an equol-producing bacterium. |
Utilizing Eggerthellaceae probiotics developed by Creative Biolabs, researchers can explore key microbiota interactions, dietary polyphenol bioavailability enhancement, and microbial ecosystem modulation. These probiotics are particularly beneficial in:
Eggerthellaceae probiotics represent an innovative frontier in microbiome modulation technologies, essential for advanced polyphenol and gut microbiota research. With comprehensive probiotic development solutions and specialized related products from Creative Biolabs, researchers are well-equipped to explore these potent microbes and their significant potential in scientific discovery.
No, urolithin production is strain-specific. Only certain species within Gordonibacter, Ellagibacter, and Adlercreutzia can metabolize ellagic acid efficiently, making precise strain screening critical for probiotic development.
Yes, but compatibility depends on shared metabolic networks and ecological tolerance. Co-culture studies must assess cross-feeding and growth inhibition. Our in vitro models support these evaluations for formulation research.
Fecal microbiota tracking via qPCR or 16S sequencing post-gavage in germ-free or antibiotic-treated mice can confirm colonization. Creative Biolabs offers customized colonization and microbiota monitoring assays.
References
For Research Use Only. Not intended for use in food manufacturing or medical procedures (diagnostics or therapeutics). Do Not Use in Humans.
Copyright © 2025 Creative Biolabs. All Rights Reserved.